JATT Acquisition
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JATT and buy or sell other stocks, ETFs, and their options commission-free!About JATT
Zura Bio Ltd. is a clinical-stage biotechnology company, which engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases.
CEOKimberly Ann Davis
CEOKimberly Ann Davis
Employees30
Employees30
HeadquartersHenderson, Nevada
HeadquartersHenderson, Nevada
Founded2022
Founded2022
Employees30
Employees30
JATT Key Statistics
Market cap241.87M
Market cap241.87M
Price-Earnings ratio-5.28
Price-Earnings ratio-5.28
Dividend yield—
Dividend yield—
Average volume303.47K
Average volume303.47K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.68
52 Week high$4.68
52 Week low$0.97
52 Week low$0.97
Stock Snapshot
JATT Acquisition(JATT) stock is priced at $3.72, giving the company a market capitalization of 241.87M. It carries a P/E multiple of -5.28.
JATT Acquisition(JATT) stock opened on 2025-12-06 at —. The price climbed to — and dipped to —.
JATT Acquisition(JATT) shares are trading with a volume of 0, against a daily average of 303.47K.
During the past year, JATT Acquisition(JATT) stock moved between $0.97 at its lowest and $4.68 at its peak.
During the past year, JATT Acquisition(JATT) stock moved between $0.97 at its lowest and $4.68 at its peak.
People also own
Based on the portfolios of people who own JATT. This list is generated using Robinhood data, and it’s not a recommendation.